A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R D Alvarez, M N Barnes, J Gomez-Navarro, M Wang, T V Strong, W Arafat, R B Arani, M R Johnson, B L Roberts, G P Siegal, D T Curiel
Institution: University of Alabama at Birmingham
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2144674318
